{
  "DOI": "10.1007/s00439-019-02020-w",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-019-02020-w",
  "alternative-id": [
    "2020"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "17 December 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "19 April 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "28 April 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "KLM receives royalties from Washington State University for MDR1 (ABCB1) genotyping patents. All the other authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-1614-2903",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Mealey",
      "given": "Katrina L.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-8430-4973",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Martinez",
      "given": "Stephanie E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Villarino",
      "given": "Nicolas F.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-2122-9977",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Court",
      "given": "Michael H.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        4,
        28
      ]
    ],
    "date-time": "2019-04-28T10:02:26Z",
    "timestamp": 1556445746000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        4,
        26
      ]
    ],
    "date-time": "2020-04-26T23:04:22Z",
    "timestamp": 1587942262000
  },
  "funder": [
    {
      "DOI": "10.13039/100001458",
      "award": [
        "2529"
      ],
      "doi-asserted-by": "publisher",
      "name": "American Kennel Club Canine Health Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        1
      ]
    ],
    "date-time": "2024-03-01T17:17:34Z",
    "timestamp": 1709313454654
  },
  "is-referenced-by-count": 22,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2019,
        4,
        28
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2019,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            4,
            28
          ]
        ],
        "date-time": "2019-04-28T00:00:00Z",
        "timestamp": 1556409600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-019-02020-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-019-02020-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-019-02020-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "467-481",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        4,
        28
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        4,
        28
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1111/vco.12084",
      "author": "S Achanta",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Vet Comp Oncol",
      "key": "2020_CR1",
      "unstructured": "Achanta S, Maxwell L (2016) Reaction phenotyping of vinblastine metabolism in dogs. Vet Comp Oncol 14:161–169",
      "volume": "14",
      "year": "2016"
    },
    {
      "DOI": "10.1124/dmd.114.058834",
      "author": "B Achour",
      "doi-asserted-by": "publisher",
      "first-page": "1349",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR2",
      "unstructured": "Achour B, Barber H, Rostami-Hodjegan A (2014) Expression of hepatic drug-metabolizing cytochrome P450 enzymes and their intercorrelations: a meta-analysis. Drug Metab Dispos 42:1349–1356",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.2460/javma.240.4.450",
      "author": "C Adami",
      "doi-asserted-by": "publisher",
      "first-page": "450",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR3",
      "unstructured": "Adami C, Axiak S, Raith K, Spadavecchia C (2012) Unusual perianesthetic malignant hyperthermia in a dog. J Am Vet Med Assoc 240:450–453",
      "volume": "240",
      "year": "2012"
    },
    {
      "DOI": "10.1097/FPC.0000000000000198",
      "author": "M Alvarellos",
      "doi-asserted-by": "publisher",
      "first-page": "138",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR4",
      "unstructured": "Alvarellos M, Krauss R, Wilke R et al (2016) PharmGKB summary: very important pharmacogene information for RYR1. Pharmacogenet Genom 26:138–144",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1365-2885.2010.01222.x",
      "author": "J Aretz",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "journal-title": "J Vet Pharmacol Ther",
      "key": "2020_CR5",
      "unstructured": "Aretz J, Geyer J (2011) Detection of the CYP1A2 1117C \u003e T polymorphism in 14 dog breeds. J Vet Pharmacol Ther 34:98–100",
      "volume": "34",
      "year": "2011"
    },
    {
      "author": "R Bagshaw",
      "first-page": "61",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR6",
      "unstructured": "Bagshaw R, Cox R, Knight D, Detweiler D (1978) Malignant hyperthermia in a Greyhound. J Am Vet Med Assoc 172:61–62",
      "volume": "172",
      "year": "1978"
    },
    {
      "DOI": "10.1080/00498250701658296",
      "author": "M Baker",
      "doi-asserted-by": "publisher",
      "first-page": "1110",
      "journal-title": "Xenobiotica",
      "key": "2020_CR7",
      "unstructured": "Baker M, Parton T (2007) Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake. Xenobiotica 37:1110–1134",
      "volume": "37",
      "year": "2007"
    },
    {
      "DOI": "10.1067/mcp.2002.121829",
      "author": "L Benet",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2020_CR8",
      "unstructured": "Benet L, Hoener B (2002) Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71:115–121",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1097/FPC.0b013e32834e1641",
      "author": "K Birdwell",
      "doi-asserted-by": "publisher",
      "first-page": "32",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR9",
      "unstructured": "Birdwell K, Grady B, Choi L et al (2012) The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genom 22:32–42",
      "volume": "22",
      "year": "2012"
    },
    {
      "author": "J Blaisdell",
      "first-page": "278",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR10",
      "unstructured": "Blaisdell J, Goldstein JA, Bai SA (1998) Isolation of a new canine cytochrome P450 cDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metab Dispos 26:278–283",
      "volume": "26",
      "year": "1998"
    },
    {
      "DOI": "10.1080/00498250600861751",
      "author": "K Bleasby",
      "doi-asserted-by": "publisher",
      "first-page": "963",
      "journal-title": "Xenobiotica",
      "key": "2020_CR11",
      "unstructured": "Bleasby K, Castle J, Roberts C et al (2006) Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963–988",
      "volume": "36",
      "year": "2006"
    },
    {
      "DOI": "10.1002/jps.23614",
      "author": "T Bohnert",
      "doi-asserted-by": "publisher",
      "first-page": "2953",
      "journal-title": "J Pharm Sci",
      "key": "2020_CR12",
      "unstructured": "Bohnert T, Gan L (2013) Plasma protein binding: from discovery to development. J Pharm Sci 102:2953–2994",
      "volume": "102",
      "year": "2013"
    },
    {
      "DOI": "10.1074/jbc.M404949200",
      "author": "O Burk",
      "doi-asserted-by": "publisher",
      "first-page": "38379",
      "journal-title": "J Biol Chem",
      "key": "2020_CR13",
      "unstructured": "Burk O, Koch I, Raucy J et al (2004) The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 279:38379–38385",
      "volume": "279",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.pharmthera.2006.04.009",
      "author": "I Cascorbi",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Pharmacol Ther",
      "key": "2020_CR14",
      "unstructured": "Cascorbi I (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–473",
      "volume": "112",
      "year": "2006"
    },
    {
      "DOI": "10.1007/978-1-60761-416-6_6",
      "author": "I Cascorbi",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Methods Mol Biol",
      "key": "2020_CR15",
      "unstructured": "Cascorbi I, Haenisch S (2010) Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Methods Mol Biol 596:95–121",
      "volume": "596",
      "year": "2010"
    },
    {
      "DOI": "10.2174/187231209787176399",
      "author": "J Chen",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "Drug Metab Lett",
      "key": "2020_CR16",
      "unstructured": "Chen J, Tran C, Xiao L et al (2009) Co-incubation of CYP3A12 and 3A26 in dog liver slices by xenobiotics: species differences between human and dog CYP3A induction. Drug Metab Lett 3:61–66",
      "volume": "3",
      "year": "2009"
    },
    {
      "DOI": "10.2460/javma.239.7.936",
      "author": "A Chohan",
      "doi-asserted-by": "publisher",
      "first-page": "936",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR17",
      "unstructured": "Chohan A, Greene S (2011) Anesthesia case of the month. Malignant hyperthermia. J Am Vet Med Assoc 239:936–940",
      "volume": "239",
      "year": "2011"
    },
    {
      "key": "2020_CR18",
      "unstructured": "Clinical Pharmacogenetics Implementation Consortium (2018) Genes-drugs. \n                    https://cpicpgx.org/genes-drugs/\n                    \n                  . Accessed 30 Nov 2018"
    },
    {
      "DOI": "10.1111/j.1365-2885.2009.01068.x",
      "author": "J Coelho",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "journal-title": "J Vet Pharmacol Ther",
      "key": "2020_CR19",
      "unstructured": "Coelho J, Tucker R, Mattoon J et al (2009) Biliary excretion of technetium-99 m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Delta mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency. J Vet Pharmacol Ther 32:417–421",
      "volume": "32",
      "year": "2009"
    },
    {
      "author": "C Cohen",
      "first-page": "1256",
      "issue": "1254",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR20",
      "unstructured": "Cohen C (1978) Malignant hyperthermia in a greyhound. J Am Vet Med Assoc 172(1254):1256",
      "volume": "172",
      "year": "1978"
    },
    {
      "DOI": "10.1016/j.cvsm.2013.05.001",
      "author": "MH Court",
      "doi-asserted-by": "publisher",
      "first-page": "1027",
      "journal-title": "Vet Clin North Am Small Anim Pract",
      "key": "2020_CR21",
      "unstructured": "Court MH (2013) Canine cytochrome P450 (CYP) pharmacogenetics. Vet Clin North Am Small Anim Pract 43:1027–1038",
      "volume": "43",
      "year": "2013"
    },
    {
      "author": "MH Court",
      "first-page": "1293",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR22",
      "unstructured": "Court MH, Hay Kraus B, Hill DW et al (1999) Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences. Drug Metab Dispos 27:1293–1299",
      "volume": "27",
      "year": "1999"
    },
    {
      "DOI": "10.1038/clpt.2013.254",
      "author": "K Crews",
      "doi-asserted-by": "publisher",
      "first-page": "376",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2020_CR23",
      "unstructured": "Crews K, Gaedigk A, Dunnenberger H et al (2014) Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 95:376–382",
      "volume": "95",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.vascn.2014.12.005",
      "author": "L Dalgaard",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "J Pharmacol Toxicol Methods",
      "key": "2020_CR24",
      "unstructured": "Dalgaard L (2015) Comparison of minipig, dog, monkey and human drug metabolism and disposition. J Pharmacol Toxicol Methods 74:80–92",
      "volume": "74",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1365-2052.1971.tb01221.x",
      "author": "M Day",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Anim Blood Groups Biochem Genet",
      "key": "2020_CR25",
      "unstructured": "Day M, Kraay G, Stevens R (1971) Polymorphism of canine serum albumin. Anim Blood Groups Biochem Genet 2:195–199",
      "volume": "2",
      "year": "1971"
    },
    {
      "DOI": "10.1136/vr.135.21.508",
      "author": "P Dickinson",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Vet Rec",
      "key": "2020_CR26",
      "unstructured": "Dickinson P, Sullivan M (1994) Exercise induced hyperthermia in a racing greyhound. Vet Rec 135:508",
      "volume": "135",
      "year": "1994"
    },
    {
      "DOI": "10.1146/annurev.pharmtox.43.100901.140251",
      "author": "X Ding",
      "doi-asserted-by": "publisher",
      "first-page": "149",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "2020_CR27",
      "unstructured": "Ding X, Kaminsky L (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149–173",
      "volume": "43",
      "year": "2003"
    },
    {
      "DOI": "10.1097/00007691-200404000-00018",
      "author": "W Evans",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "journal-title": "Ther Drug Monit",
      "key": "2020_CR28",
      "unstructured": "Evans W (2004) Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther Drug Monit 26:186–191",
      "volume": "26",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.rvsc.2016.03.016",
      "author": "Z Firdova",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Res Vet Sci",
      "key": "2020_CR29",
      "unstructured": "Firdova Z, Turnova E, Bielikova M et al (2016) The prevalence of ABCB1:c.227_230delATAG mutation in affected dog breeds from European countries. Res Vet Sci 106:89–92",
      "volume": "106",
      "year": "2016"
    },
    {
      "author": "D Fraser",
      "first-page": "1425",
      "journal-title": "J Pharmacoly Exp Ther",
      "key": "2020_CR30",
      "unstructured": "Fraser D, Feyereisen R, Harlow G, Halpter J (1997) Isolation, heterologous expresion and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library. J Pharmacoly Exp Ther 283:1425–1432",
      "volume": "283",
      "year": "1997"
    },
    {
      "DOI": "10.1016/j.jmb.2005.07.075",
      "author": "J Ghuman",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "journal-title": "J Mol Biol",
      "key": "2020_CR31",
      "unstructured": "Ghuman J, Zunszain P, Petitpas I et al (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353:38–52",
      "volume": "353",
      "year": "2005"
    },
    {
      "DOI": "10.1097/FPC.0000000000000297",
      "author": "L Gong",
      "doi-asserted-by": "publisher",
      "first-page": "337",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR32",
      "unstructured": "Gong L, Zhang C, Lv J et al (2017) Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy. Pharmacogenet Genom 27:337–346",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1080/0049825021000048782",
      "author": "M Graham",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Xenobiotica",
      "key": "2020_CR33",
      "unstructured": "Graham M, Bell A, Crewe K et al (2003) mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Xenobiotica 33:225–237",
      "volume": "33",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.tvjl.2010.06.012",
      "author": "I Gramer",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "Vet J",
      "key": "2020_CR34",
      "unstructured": "Gramer I, Leidolf R, Döring B et al (2011) Breed distribution of the nt230(del4) MDR1 mutation in dogs. Vet J 189:67–71",
      "volume": "189",
      "year": "2011"
    },
    {
      "DOI": "10.2217/14622416.9.5.625",
      "author": "A Gunes",
      "doi-asserted-by": "publisher",
      "first-page": "625",
      "journal-title": "Pharmacogenomics",
      "key": "2020_CR35",
      "unstructured": "Gunes A, Dahl M (2008) Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 9:625–637",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1080/004982500406417",
      "author": "B Hay Kraus",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Xenobiotica",
      "key": "2020_CR36",
      "unstructured": "Hay Kraus B, Greenblatt D, Venkatakrishnan K, Court MH (2000) Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes; breed and gender differences. Xenobiotica 30:575–588",
      "volume": "30",
      "year": "2000"
    },
    {
      "DOI": "10.1038/358209a0",
      "author": "X He",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "journal-title": "Nature",
      "key": "2020_CR37",
      "unstructured": "He X, Carter D (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215",
      "volume": "358",
      "year": "1992"
    },
    {
      "DOI": "10.1016/j.apsb.2016.07.016",
      "author": "W Hedrich",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "journal-title": "Acta Pharm Sin B",
      "key": "2020_CR38",
      "unstructured": "Hedrich W, Hassan H, Wang H (2016) Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B 6:413–425",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s11095-014-1446-8",
      "author": "A Heikkinen",
      "doi-asserted-by": "publisher",
      "first-page": "74",
      "journal-title": "Pharm Res",
      "key": "2020_CR39",
      "unstructured": "Heikkinen A, Friedlein A, Matondo M et al (2015) Quantitative ADME proteomics—CYP and UGT enzymes in the Beagle dog liver and intestine. Pharm Res 32:74–90",
      "volume": "32",
      "year": "2015"
    },
    {
      "DOI": "10.3390/ijms19020394",
      "author": "B Hernandez",
      "doi-asserted-by": "publisher",
      "first-page": "E394",
      "journal-title": "Int J Mol Sci",
      "key": "2020_CR40",
      "unstructured": "Hernandez B, Adissu H, Wei B et al (2018) Naturally occurring canine melanoma as a predictive comparative oncology model for human mucosal and other triple wild-type melanomas. Int J Mol Sci 19:E394",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1124/dmd.118.083030",
      "author": "N Heyes",
      "doi-asserted-by": "publisher",
      "first-page": "1886",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR41",
      "unstructured": "Heyes N, Kapoor P, Kerr I (2018) Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function, and drug pharmacokinetics. Drug Metab Dispos 46:1886–1899",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1002/jps.21520",
      "author": "T Ito",
      "doi-asserted-by": "publisher",
      "first-page": "1545",
      "journal-title": "J Pharm Sci",
      "key": "2020_CR42",
      "unstructured": "Ito T, Takahashi M, Sudo K, Sugiyama Y (2009) Interindividual pharmacokinetics variability of the alpha(4)beta(1) integrin antagonist, 4-[1-[3-chloro-4-[N’-(2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]methoxybenzoic acid (D01-4582), in beagles is associated with albumin gene. J Pharm Sci 98:1545–1555",
      "volume": "98",
      "year": "2009"
    },
    {
      "DOI": "10.1080/00480169.1985.35241",
      "author": "P Jerram",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "journal-title": "N Z Vet J",
      "key": "2020_CR43",
      "unstructured": "Jerram P (1985) Adverse reaction to ivermectin in a rough-coated Collie. N Z Vet J 33:216",
      "volume": "33",
      "year": "1985"
    },
    {
      "DOI": "10.1097/01.fpc.0000204994.99429.46",
      "author": "Z Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR44",
      "unstructured": "Jiang Z, Dragin N, Jorge-Nebert L et al (2006) Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenet Genom 16:359–367",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1124/dmd.107.016873",
      "author": "K Kaneko",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR45",
      "unstructured": "Kaneko K, Fukuda H, Chuang V et al (2008) Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug Metab Dispos 36:81–86",
      "volume": "36",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1939-1676.2004.tb00163.x",
      "author": "L Kidd",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "J Vet Intern Med",
      "key": "2020_CR46",
      "unstructured": "Kidd L, Salavaggione O, Szumlanski C et al (2004) Thiopurine methyltransferase activity in red blood cells of dogs. J Vet Intern Med 18:214–218",
      "volume": "18",
      "year": "2004"
    },
    {
      "author": "A Kirmayer",
      "first-page": "978",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR47",
      "unstructured": "Kirmayer A, Lkide A, Purvance J (1984) Malignant hyperthermia in a dog: case report and review of the syndrome. J Am Vet Med Assoc 185:978–982",
      "volume": "185",
      "year": "1984"
    },
    {
      "author": "T Kosa",
      "first-page": "1607",
      "journal-title": "Drug binding sites. Pharm Res",
      "key": "2020_CR48",
      "unstructured": "Kosa T, Maruyama T, Otagiri M (1997) Species differences of serum albumins: I. Drug binding sites. Pharm Res 14:1607–1612",
      "volume": "14",
      "year": "1997"
    },
    {
      "DOI": "10.1002/jps.20887",
      "author": "T Kosa",
      "doi-asserted-by": "publisher",
      "first-page": "3117",
      "journal-title": "J Pharm Sci",
      "key": "2020_CR49",
      "unstructured": "Kosa T, Nishi K, Maruyama T et al (2007) Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface. J Pharm Sci 96:3117–3124",
      "volume": "96",
      "year": "2007"
    },
    {
      "author": "S Leary",
      "first-page": "521",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR50",
      "unstructured": "Leary S, Anderson L, Manning P et al (1983) Recurrent malignant hyperthermia in a Greyhound. J Am Vet Med Assoc 182:521–522",
      "volume": "182",
      "year": "1983"
    },
    {
      "DOI": "10.1038/nature04338",
      "author": "K Lindblad-Toh",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "journal-title": "Nature",
      "key": "2020_CR51",
      "unstructured": "Lindblad-Toh K, Wade CM, Mikkelsen TS et al (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803–819. \n                    https://doi.org/10.1038/nature04338",
      "volume": "438",
      "year": "2005"
    },
    {
      "DOI": "10.1124/dmd.108.025312",
      "author": "C Locuson",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR52",
      "unstructured": "Locuson C, Ethell B, Voice M et al (2009) Evaluation of Esherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase. Drug Metab Dispos 37:457–461",
      "volume": "37",
      "year": "2009"
    },
    {
      "DOI": "10.1111/jvp.12256",
      "author": "C Locuson",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "journal-title": "Vet Pharmacol Ther",
      "key": "2020_CR53",
      "unstructured": "Locuson C, Williams P, Adcock J, Daniels J (2015) Evaluation of tizanidine as a marker of canine CYP1A2 activity. Vet Pharmacol Ther 39:122–130",
      "volume": "39",
      "year": "2015"
    },
    {
      "DOI": "10.1053/j.tcam.2009.02.002",
      "author": "C London",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "Top Companion Anim Med",
      "key": "2020_CR54",
      "unstructured": "London C (2009) Tyrosine kinase inhibitors in veterinary medicine. Top Companion Anim Med 24:106–112",
      "volume": "24",
      "year": "2009"
    },
    {
      "DOI": "10.1124/pr.110.003533",
      "author": "Q Ma",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "journal-title": "Pharmacol Rev",
      "key": "2020_CR55",
      "unstructured": "Ma Q, Lu A (2011) Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev 63:437–459",
      "volume": "63",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.rvsc.2013.02.021",
      "author": "B Maran",
      "doi-asserted-by": "publisher",
      "first-page": "238",
      "journal-title": "Res Vet Sci",
      "key": "2020_CR56",
      "unstructured": "Maran B, Mealey KL, Lahmers S et al (2013) Identification of DNA variants in the canine beta-1 adrenergic receptor gene. Res Vet Sci 95:238–240",
      "volume": "95",
      "year": "2013"
    },
    {
      "DOI": "10.3109/03602532.2013.765445",
      "author": "M Martinez",
      "doi-asserted-by": "publisher",
      "first-page": "218",
      "journal-title": "Drug Metab Rev",
      "key": "2020_CR57",
      "unstructured": "Martinez M, Antonovic L, Court M et al (2013) Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metab Rev 45:218–230",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1111/jvp.12670",
      "author": "MN Martinez",
      "doi-asserted-by": "publisher",
      "first-page": "E57",
      "journal-title": "J Vet Pharmacol Ther",
      "key": "2020_CR58",
      "unstructured": "Martinez MN, Court MH, Fink-Gremmels J, Mealey KL (2018) Population variability in animal health: influence on dose-exposure-response relationships: Part 1: drug metabolism and transporter systems. J Vet Pharmacol Ther 41:E57–E67",
      "volume": "41",
      "year": "2018"
    },
    {
      "DOI": "10.1111/j.1365-2885.2004.00607.x",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "J Vet Pharmacol Ther",
      "key": "2020_CR59",
      "unstructured": "Mealey KL (2004) Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 27:257–264",
      "volume": "27",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.vetpar.2008.09.009",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Vet Parasitol",
      "key": "2020_CR60",
      "unstructured": "Mealey KL (2008) Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics. Vet Parasitol 158:215–222",
      "volume": "158",
      "year": "2008"
    },
    {
      "DOI": "10.1111/jvim.12525",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Vet Intern Med",
      "key": "2020_CR61",
      "unstructured": "Mealey KL, Fidel J (2015) P-glycoprotein mediated drug interactions in animals and humans with cancer. J Vet Intern Med 29:1–6",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.2460/javma.233.6.921",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "921",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR62",
      "unstructured": "Mealey KL, Meurs K (2008) Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping. J Am Vet Med Assoc 233:921–924",
      "volume": "233",
      "year": "2008"
    },
    {
      "DOI": "10.1097/00008571-200111000-00012",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "Pharmacogenetics",
      "key": "2020_CR63",
      "unstructured": "Mealey KL, Bentjen S, Gay J, Cantor G (2001) Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11:727–733",
      "volume": "11",
      "year": "2001"
    },
    {
      "DOI": "10.1111/j.1939-1676.2008.0122.x",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "996",
      "journal-title": "J Vet Intern Med",
      "key": "2020_CR64",
      "unstructured": "Mealey KL, Fidel J, Gay J et al (2008a) ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine. J Vet Intern Med 22:996–1000",
      "volume": "22",
      "year": "2008"
    },
    {
      "DOI": "10.1124/dmd.107.018978",
      "author": "KL Mealey",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR65",
      "unstructured": "Mealey KL, Greene S, Bagley R et al (2008b) P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine P-glycoprotein knockout model. Drug Metab Dispos 36:1073–1079",
      "volume": "36",
      "year": "2008"
    },
    {
      "DOI": "10.1097/FPC.0000000000000152",
      "author": "K Meurs",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR66",
      "unstructured": "Meurs K, Stern J, Reina-Doreste Y et al (2015) Impact of the canine double-deletion β1 adrenoreceptor polymorphisms on protein structure and heart rate response to atenolol, a β1-selective β-blocker. Pharmacogenet Genom 25:427–431",
      "volume": "25",
      "year": "2015"
    },
    {
      "author": "M Mgheni",
      "first-page": "307",
      "journal-title": "Hereditas",
      "key": "2020_CR67",
      "unstructured": "Mgheni M, Christensen K, Andresen E (1979) Albumin polymorphism in domestic dog breeds. Hereditas 91:307–308",
      "volume": "91",
      "year": "1979"
    },
    {
      "DOI": "10.1016/j.bja.2018.06.028",
      "author": "D Miller",
      "doi-asserted-by": "publisher",
      "first-page": "944",
      "journal-title": "Br J Anaesth",
      "key": "2020_CR68",
      "unstructured": "Miller D, Daly C, Aboelsaod E et al (2018) Genetic epidemiology of malignant hyperthermia in the UK. Br J Anaesth 121:944–952",
      "volume": "121",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.20754",
      "author": "L Minchiotti",
      "doi-asserted-by": "publisher",
      "first-page": "1007",
      "journal-title": "Hum Mutat",
      "key": "2020_CR69",
      "unstructured": "Minchiotti L, Calliano M, Kragh-Hansen U, Peters TJ (2008) Mutations and polymorphisms of the gene of the major human blood protein, serum albumin. Hum Mutat 29:1007–1016",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1097/00008571-200411000-00008",
      "author": "M Mise",
      "doi-asserted-by": "publisher",
      "first-page": "769",
      "journal-title": "Pharmacogenetics",
      "key": "2020_CR70",
      "unstructured": "Mise M, Hashizume T, Matsumoto S et al (2004a) Identification of non-functional allelic variant of CYP1A2 in dogs. Pharmacogenetics 14:769–773",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1124/dmd.32.2.240",
      "author": "M Mise",
      "doi-asserted-by": "publisher",
      "first-page": "240",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR71",
      "unstructured": "Mise M, Yadera S, Matsuda M et al (2004b) Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs. Drug Metab Dispos 32:240–245",
      "volume": "32",
      "year": "2004"
    },
    {
      "DOI": "10.1124/dmd.108.022301",
      "author": "M Mise",
      "doi-asserted-by": "publisher",
      "first-page": "1903",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR72",
      "unstructured": "Mise M, Hashizume T, Komuro S (2008) Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes. Drug Metab Dispos 36:1903–1908",
      "volume": "36",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1479-5876-11-158",
      "author": "N Monks",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "J Transl Med",
      "key": "2020_CR73",
      "unstructured": "Monks N, Cherba D, Kamerling S et al (2013) A multi-site feasibility study for personalized medicine in canines with osteosarcoma. J Transl Med 11:158",
      "volume": "11",
      "year": "2013"
    },
    {
      "author": "M Monobe",
      "first-page": "111",
      "journal-title": "Vet Med (Auckland, NZ)",
      "key": "2020_CR74",
      "unstructured": "Monobe M, Junior J, Lunsford K et al (2015) Frequency of the MDR1 mutant allele associated with multidrug sensitivity in dogs from Brazil. Vet Med (Auckland, NZ) 6:111–117",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/d41586-018-05771-0",
      "author": "L Moses",
      "doi-asserted-by": "publisher",
      "first-page": "470",
      "journal-title": "Nature",
      "key": "2020_CR75",
      "unstructured": "Moses L, Niemi S, Karlsson E (2018) Pet genomics medicine runs wild. Nature 559:470–472",
      "volume": "559",
      "year": "2018"
    },
    {
      "DOI": "10.1073/pnas.0402374101",
      "author": "MW Neff",
      "doi-asserted-by": "publisher",
      "first-page": "11725",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "2020_CR76",
      "unstructured": "Neff MW, Robertson KR, Wong AK et al (2004) Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci USA 101:11725–11730",
      "volume": "101",
      "year": "2004"
    },
    {
      "author": "T Nelson",
      "first-page": "989",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR77",
      "unstructured": "Nelson T (1991) Malignant hyperthermia in dogs. J Am Vet Med Assoc 198:989–994",
      "volume": "198",
      "year": "1991"
    },
    {
      "author": "P O’Brien",
      "first-page": "172",
      "journal-title": "Can Vet J",
      "key": "2020_CR78",
      "unstructured": "O’Brien P, Cribb P, White R et al (1983) Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony. Can Vet J 24:172–177",
      "volume": "24",
      "year": "1983"
    },
    {
      "DOI": "10.1016/S0034-5288(18)31522-4",
      "author": "P O’Brien",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "journal-title": "Res Vet Sci",
      "key": "2020_CR79",
      "unstructured": "O’Brien P, Pook H, Klip A et al (1990) Canine stress syndrome/malignant hyperthermia susceptibility: calcium-homeostasis defect in muscle and lymphocytes. Res Vet Sci 48:124–128",
      "volume": "48",
      "year": "1990"
    },
    {
      "author": "K Otto",
      "first-page": "519",
      "journal-title": "Tierarztl Prax",
      "key": "2020_CR80",
      "unstructured": "Otto K (1992) Malignant hyperthermia as a complication of anesthesia in the dog. Tierarztl Prax 20:519–522",
      "volume": "20",
      "year": "1992"
    },
    {
      "DOI": "10.3389/fphar.2014.00103",
      "author": "AV Pandey",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Front Pharmacol",
      "key": "2020_CR81",
      "unstructured": "Pandey AV, Sproll P (2014) Pharmacogenomics of human P450 oxidoreductase. Front Pharmacol 5:103",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.celrep.2017.03.079",
      "author": "HG Parker",
      "doi-asserted-by": "publisher",
      "first-page": "697",
      "journal-title": "Cell Rep",
      "key": "2020_CR82",
      "unstructured": "Parker HG, Dreger D, Rimbault M et al (2017) Genomic analyses reveal the influence of geographic organization, migration and hybridization on modern dog breed development. Cell Rep 19:697–708",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1111/1755-5922.12030",
      "author": "H Parry",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "journal-title": "Cardiovasc Ther",
      "key": "2020_CR83",
      "unstructured": "Parry H, Doney A, Palmer C, Lang C (2013) State of play of pharmacogenetics and personalized medicine in heart failure. Cardiovasc Ther 31:315–322",
      "volume": "31",
      "year": "2013"
    },
    {
      "author": "S Paulson",
      "first-page": "1133",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR84",
      "unstructured": "Paulson S, Engel L, Reitz B et al (1999) Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27:1133–1142",
      "volume": "27",
      "year": "1999"
    },
    {
      "DOI": "10.1111/jvp.12706",
      "author": "T Perez Jimenez",
      "doi-asserted-by": "publisher",
      "first-page": "815",
      "journal-title": "Vet Pharmacol Ther",
      "key": "2020_CR85",
      "unstructured": "Perez Jimenez T, Mealey K, Schnider D et al (2018) Identification of canine cytochrome P-450 s (CYPs) metabolizing the tramadol (+)-M1 and (+)-M2 metabolites to the tramadol (+)-M5 metabolite in dog liver microsomes. Vet Pharmacol Ther 41:815–824",
      "volume": "41",
      "year": "2018"
    },
    {
      "DOI": "10.1124/dmd.116.071902",
      "author": "TE Perez",
      "doi-asserted-by": "publisher",
      "first-page": "1963",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR86",
      "unstructured": "Perez TE, Mealey KL, Grubb TL et al (2016) Tramadol metabolism to O-desmethyl tramadol (M1) and N-desmethyl tramadol (M2) by dog liver microsomes: species comparison and identification of responsible canine cytochrome P450s. Drug Metab Dispos 44:1963–1972",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmg.31.5.355",
      "author": "C Petersen",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "J Med Genet",
      "key": "2020_CR87",
      "unstructured": "Petersen C, Scottolini A, Cody L et al (1994) A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia. J Med Genet 31:355–359",
      "volume": "31",
      "year": "1994"
    },
    {
      "DOI": "10.1006/bbrc.1995.2402",
      "author": "C Petersen",
      "doi-asserted-by": "publisher",
      "first-page": "1121",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "2020_CR88",
      "unstructured": "Petersen C, Ha C, Mandel M, Bhagavan N (1995) Expression of a human serum albumin variant with high affinity for thyroxine. Biochem Biophys Res Commun 214:1121–1129",
      "volume": "214",
      "year": "1995"
    },
    {
      "key": "2020_CR89",
      "unstructured": "Pharmacogene Variation Consortium (2018) PharmVar. In: PharmVar database 3.2. \n                    https://www.pharmvar.org/\n                    \n                  . Accessed 5 Dec 2018"
    },
    {
      "DOI": "10.1002/chir.20521",
      "author": "M Pistolozzi",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "journal-title": "Chirality",
      "key": "2020_CR90",
      "unstructured": "Pistolozzi M, Bertucci C (2008) Species-dependent stereoselective drug binding to albumin: a circular dichroism study. Chirality 20:552–558",
      "volume": "20",
      "year": "2008"
    },
    {
      "author": "J Rand",
      "first-page": "1013",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR91",
      "unstructured": "Rand J, O’Brien P (1987) Exercise-induced malignant hyperthermia in an English springer spaniel. J Am Vet Med Assoc 190:1013–1014",
      "volume": "190",
      "year": "1987"
    },
    {
      "DOI": "10.1097/00000542-200109000-00026",
      "author": "M Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "716",
      "journal-title": "Anesthesiology",
      "key": "2020_CR92",
      "unstructured": "Roberts M, Mickelson J, Patterson E et al (2001) Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 95:716–725",
      "volume": "95",
      "year": "2001"
    },
    {
      "DOI": "10.1111/j.1939-1676.2004.tb02555.x",
      "author": "D Rodriguez",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "journal-title": "J Vet Intern Med",
      "key": "2020_CR93",
      "unstructured": "Rodriguez D, Mackin A, Easley R et al (2004) Relationship between red blood cell thiopurine methyltransferase activity and myelotoxicity in dogs receiving azathioprine. J Vet Intern Med 18:339–345",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.1186/s13023-015-0310-1",
      "author": "H Rosenberg",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Orphanet J Rare Dis",
      "key": "2020_CR94",
      "unstructured": "Rosenberg H, Pollock N, Schiemann A et al (2015) Malignant hyperthermia: a review. Orphanet J Rare Dis 10:93",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1476-5381.2011.01724.x",
      "author": "M Roth",
      "doi-asserted-by": "publisher",
      "first-page": "1260",
      "journal-title": "Br J Pharmacol",
      "key": "2020_CR95",
      "unstructured": "Roth M, Obaidat A, Hagenbuch B (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–1287",
      "volume": "165",
      "year": "2012"
    },
    {
      "DOI": "10.1006/abbi.1998.0801",
      "author": "F Roussel",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Arch Biochem Biophys",
      "key": "2020_CR96",
      "unstructured": "Roussel F, Duignan D, Lawton M et al (1998) Expression and characterization of canine cytochrome P450 2D15. Arch Biochem Biophys 357:27–36",
      "volume": "357",
      "year": "1998"
    },
    {
      "DOI": "10.1006/abbi.1995.1307",
      "author": "K Sakamoto",
      "doi-asserted-by": "publisher",
      "first-page": "372",
      "journal-title": "Arch Biochem Biophys",
      "key": "2020_CR97",
      "unstructured": "Sakamoto K, Kirita S, Baba T et al (1995) A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Arch Biochem Biophys 319:372–382",
      "volume": "319",
      "year": "1995"
    },
    {
      "DOI": "10.1097/00008571-200212000-00005",
      "author": "O Salavaggione",
      "doi-asserted-by": "publisher",
      "first-page": "713",
      "journal-title": "Pharmacogenetics",
      "key": "2020_CR98",
      "unstructured": "Salavaggione O, Kidd L, Prondzinski J et al (2002) Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. Pharmacogenetics 12:713–724",
      "volume": "12",
      "year": "2002"
    },
    {
      "author": "R Sams",
      "first-page": "245",
      "journal-title": "Am J Vet Res",
      "key": "2020_CR99",
      "unstructured": "Sams R, Muir W (1988) Effects of phenobarbital on thiopental pharmacokinetics in greyhounds. Am J Vet Res 49:245–249",
      "volume": "49",
      "year": "1988"
    },
    {
      "author": "R Sams",
      "first-page": "1677",
      "journal-title": "Am J Vet Res",
      "key": "2020_CR100",
      "unstructured": "Sams R, Muir W, Detra R, Robinson E (1985) Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. Am J Vet Res 46:1677–1683",
      "volume": "46",
      "year": "1985"
    },
    {
      "author": "D Sawyer",
      "first-page": "341",
      "journal-title": "J Am Vet Med Assoc",
      "key": "2020_CR101",
      "unstructured": "Sawyer D (1981) Malignant hyperthermia. J Am Vet Med Assoc 179:341–344",
      "volume": "179",
      "year": "1981"
    },
    {
      "DOI": "10.1111/j.1365-2885.2010.01243.x",
      "author": "M Scherr",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "J Vet Pharmacol Ther",
      "key": "2020_CR102",
      "unstructured": "Scherr M, Lourenço G, Albuquerque D, Lima C (2011) Polymorphism of cytochrome P450 A2 (CYP1A2) in pure and mixed breed dogs. J Vet Pharmacol Ther 34:184–186",
      "volume": "34",
      "year": "2011"
    },
    {
      "DOI": "10.1172/JCI118214",
      "author": "A Schinkel",
      "doi-asserted-by": "publisher",
      "first-page": "1698",
      "journal-title": "J Clin Invest",
      "key": "2020_CR103",
      "unstructured": "Schinkel A, Wagenaar E, van Deemter L et al (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698–1705",
      "volume": "96",
      "year": "1995"
    },
    {
      "DOI": "10.1097/00000542-197310000-00033",
      "author": "C Short",
      "doi-asserted-by": "publisher",
      "first-page": "462",
      "journal-title": "Anesthesiology",
      "key": "2020_CR104",
      "unstructured": "Short C, Paddleford R (1973) Letter: malignant hyperthermia in the dog. Anesthesiology 39:462–463",
      "volume": "39",
      "year": "1973"
    },
    {
      "DOI": "10.1124/dmd.31.9.1161",
      "author": "M Shou",
      "doi-asserted-by": "publisher",
      "first-page": "1161",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR105",
      "unstructured": "Shou M, Norcross R, Sandbig G et al (2003) Substrate specificity and kinetic properties of seven heterologously expressed dog cytochrome P450. Drug Metab Dispos 31:1161–1169",
      "volume": "31",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.clpt.2004.03.003",
      "author": "A Sparreboom",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2020_CR106",
      "unstructured": "Sparreboom A, Gelderblom H, Marsh S et al (2004) Diflomotecan pharmacokinetics in relation to ABCG2 421C \u003e A genotype. Clin Pharmacol Ther 76:38–44",
      "volume": "76",
      "year": "2004"
    },
    {
      "DOI": "10.2165/11317350-000000000-00000",
      "author": "C Staatz",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "journal-title": "Clin Pharmacokinet",
      "key": "2020_CR107",
      "unstructured": "Staatz C, Goodman L, Tett S (2010a) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacoknetics and pharmacodynamics of calcineurin inhibitors: part I. Clin Pharmacokinet 49:141–175",
      "volume": "49",
      "year": "2010"
    },
    {
      "DOI": "10.2165/11317550-000000000-00000",
      "author": "C Staatz",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Clin Pharmacokinet",
      "key": "2020_CR108",
      "unstructured": "Staatz C, Goodman L, Tett S (2010b) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacoknetics and pharmacodynamics of calcineurin inhibitors: part II. Clin Pharmacokinet 49:207–221",
      "volume": "49",
      "year": "2010"
    },
    {
      "author": "G Sudlow",
      "first-page": "824",
      "journal-title": "Mol Pharmacol",
      "key": "2020_CR109",
      "unstructured": "Sudlow G, Birkett D, Wade D (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11:824–832",
      "volume": "11",
      "year": "1975"
    },
    {
      "DOI": "10.1093/protein/12.6.439",
      "author": "S Sugio",
      "doi-asserted-by": "publisher",
      "first-page": "439",
      "journal-title": "Protein Eng",
      "key": "2020_CR110",
      "unstructured": "Sugio S, Kashima A, Mochizuki S et al (1999) Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng 12:439–446",
      "volume": "12",
      "year": "1999"
    },
    {
      "DOI": "10.1006/bbrc.1994.1998",
      "author": "T Sunthornthepvarakul",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "2020_CR111",
      "unstructured": "Sunthornthepvarakul T, Angkeow P, Weiss R et al (1994) An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun 202:781–787",
      "volume": "202",
      "year": "1994"
    },
    {
      "DOI": "10.1080/00498250412331285436",
      "author": "D Tenmizu",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "journal-title": "Xenobiotica",
      "key": "2020_CR112",
      "unstructured": "Tenmizu D, Endo Y, Noguchi K, Kaminura H (2004) Identification of the novel canine CYP1A2 1117 C \u003e T SNP causing protein deletion. Xenobiotica 34:835–846",
      "volume": "34",
      "year": "2004"
    },
    {
      "DOI": "10.1124/dmd.105.008722",
      "author": "D Tenmizu",
      "doi-asserted-by": "publisher",
      "first-page": "800",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR113",
      "unstructured": "Tenmizu D, Noguchi K, Kaminura H et al (2006a) The canine CYP1A2 deficiency polymorphism dramatically affects the pharmacokinetics of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-d]-pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4 inhibitor. Drug Metab Dispos 34:800–806",
      "volume": "34",
      "year": "2006"
    },
    {
      "DOI": "10.1124/dmd.106.011213",
      "author": "D Tenmizu",
      "doi-asserted-by": "publisher",
      "first-page": "1811",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR114",
      "unstructured": "Tenmizu D, Noguchi K, Kaminura H (2006b) Elucidation of the effects of the CYP1A2 deficiency polymorphism in the metabolism of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-d]pyrimidine-2-(1 h)-one (YM-64227), a phosphodiesterase type 4 inhibitor, and its metabolites in dogs. Drug Metab Dispos 34:1811–1816",
      "volume": "34",
      "year": "2006"
    },
    {
      "author": "E Thrift",
      "first-page": "59",
      "journal-title": "Vet Med",
      "key": "2020_CR115",
      "unstructured": "Thrift E, Wimpole J, Child G et al (2017) Exercise-induced hyperthermia syndrome (canine stress syndrome) in four related male English springer spaniels. Vet Med 8:59",
      "volume": "8",
      "year": "2017"
    },
    {
      "author": "T Uchida",
      "first-page": "644",
      "journal-title": "Mol Pharmacol",
      "key": "2020_CR116",
      "unstructured": "Uchida T, Komori M, Kitada M, Kamataki T (1990) Isolation of cDNAs coding for three diferent forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated Beagle dogs. Mol Pharmacol 38:644–651",
      "volume": "38",
      "year": "1990"
    },
    {
      "key": "2020_CR117",
      "unstructured": "U.S. Food \u0026 Drug Administration (2010) FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. \n                    https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm203888.htm\n                    \n                  . Accessed 10 Dec 2018"
    },
    {
      "key": "2020_CR118",
      "unstructured": "U.S. Food \u0026 Drug Administration (2018) Table of pharmacogenomic biomarkers in drug labeling. \n                    https://www.fda.gov/Drugs/ScienceResearch/ucm572698.htm\n                    \n                  . Accessed 31 Oct 2018"
    },
    {
      "DOI": "10.1016/j.clpt.2003.10.008",
      "author": "O Richter Von",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2020_CR119",
      "unstructured": "Von Richter O, Burk O, Fromm MF et al (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 14:172–183. \n                    https://doi.org/10.1016/j.clpt.2003.10.008",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1210/jcem.82.10.4276",
      "author": "N Wada",
      "doi-asserted-by": "publisher",
      "first-page": "3246",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "2020_CR120",
      "unstructured": "Wada N, Chiba H, Shimizu C et al (1997) A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab 82:3246–3250",
      "volume": "82",
      "year": "1997"
    },
    {
      "DOI": "10.1097/FPC.0b013e3283352860",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "401",
      "journal-title": "Pharmacogenet Genom",
      "key": "2020_CR121",
      "unstructured": "Wang L, Pelleymounter L, Weinshilboum R et al (2010a) Very important pharmacogene summary: thiopurine S-methyltransferase. Pharmacogenet Genom 20:401–405",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.2217/pgs.10.105",
      "author": "P Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1389",
      "journal-title": "Pharmacogenomics",
      "key": "2020_CR122",
      "unstructured": "Wang P, Mao Y, Razo J et al (2010b) Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients. Pharmacogenomics 11:1389–1402",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pone.0188667",
      "author": "G Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e0188667",
      "journal-title": "PLoS One",
      "key": "2020_CR123",
      "unstructured": "Wang G, Wu M, Maloneyhuss M et al (2017) Actionable mutations in canine hemangiosarcoma. PLoS One 12:e0188667",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMra020021",
      "author": "R Weinshilboum",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "journal-title": "N Engl J Med",
      "key": "2020_CR124",
      "unstructured": "Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348:529–537",
      "volume": "348",
      "year": "2003"
    },
    {
      "author": "A Wenker",
      "key": "2020_CR125",
      "unstructured": "Wenker A (2009) Genetic variations in the canine CYP2B11 gene: implications for veteirnary medicine?. Ultrecht University, Ultrecht",
      "volume-title": "Genetic variations in the canine CYP2B11 gene: implications for veteirnary medicine?",
      "year": "2009"
    },
    {
      "DOI": "10.1038/clpt.2012.96",
      "author": "M Whirl-Carrillo",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2020_CR126",
      "unstructured": "Whirl-Carrillo M, McDonagh E, Hebert J et al (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414–417",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.2174/187231207780363688",
      "author": "V Whiterock",
      "doi-asserted-by": "publisher",
      "first-page": "163",
      "journal-title": "Drug Metab Lett",
      "key": "2020_CR127",
      "unstructured": "Whiterock V, Delmonte T, Hui L et al (2007) Frequency of CYP1A2 polymorphism in beagle dogs. Drug Metab Lett 1:163–165",
      "volume": "1",
      "year": "2007"
    },
    {
      "DOI": "10.1124/dmd.111.041848",
      "author": "V Whiterock",
      "doi-asserted-by": "publisher",
      "first-page": "228",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR128",
      "unstructured": "Whiterock V, Morgan D, Lentz K et al (2012) Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs. Drug Metab Dispos 40:228–231",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1124/dmd.104.000794",
      "author": "J Williams",
      "doi-asserted-by": "publisher",
      "first-page": "1201",
      "journal-title": "Drug Metab Dispos",
      "key": "2020_CR129",
      "unstructured": "Williams J, Hyland R, Jones B et al (2004) Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 32:1201–1208",
      "volume": "32",
      "year": "2004"
    },
    {
      "DOI": "10.1038/srep36782",
      "author": "K Yamada",
      "doi-asserted-by": "publisher",
      "first-page": "36782",
      "journal-title": "Sci Rep",
      "key": "2020_CR130",
      "unstructured": "Yamada K, Okomaku K, Kureishi M et al (2016) Artificial blood for dogs. Sci Rep 6:36782",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.23635",
      "author": "I Zaharieva",
      "doi-asserted-by": "publisher",
      "first-page": "1980",
      "journal-title": "Hum Mutat",
      "key": "2020_CR131",
      "unstructured": "Zaharieva I, Sarkozy A, Munot P et al (2018) STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility. Hum Mutat 39:1980–1994",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fgene.2013.00024",
      "author": "UM Zanger",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "journal-title": "Front Genet",
      "key": "2020_CR132",
      "unstructured": "Zanger UM, Klein K (2013) Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet 4:24",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.pharmthera.2012.12.007",
      "author": "U Zanger",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Pharmacol Ther",
      "key": "2020_CR133",
      "unstructured": "Zanger U, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activitites, and impact of genetic variation. Pharmacol Ther 138:103–141",
      "volume": "138",
      "year": "2013"
    },
    {
      "DOI": "10.1124/dmd.110.033068",
      "author": "S Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1015",
      "journal-title": "Drug Metab Rev",
      "key": "2020_CR134",
      "unstructured": "Zhou S, Wang B, Yang L, Liu J (2010) Structure, function, regulation, and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 38:1015–1018",
      "volume": "38",
      "year": "2010"
    },
    {
      "author": "D Zoran",
      "first-page": "755",
      "journal-title": "Am J Vet Res",
      "key": "2020_CR135",
      "unstructured": "Zoran D, Riedesel D, Dyer D (1993) Pharmacokinetics of propofol in mixed-breed dogs and greyhounds. Am J Vet Res 54:755–760",
      "volume": "54",
      "year": "1993"
    },
    {
      "DOI": "10.1093/bioinformatics/btr284",
      "author": "F Zsila",
      "doi-asserted-by": "publisher",
      "first-page": "1806",
      "journal-title": "Bioinformatics",
      "key": "2020_CR136",
      "unstructured": "Zsila F, Bikadi Z, Malik D et al (2011) Evaluation of drug-human serum albumin binding interactions with support vector machine aided online automated docking. Bioinformatics 27:1806–1813",
      "volume": "27",
      "year": "2011"
    }
  ],
  "reference-count": 136,
  "references-count": 136,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-019-02020-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Personalized medicine: going to the dogs?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "138"
}